Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/2004
06/02/2004EP1423524A2 Method of protein production in plants
06/02/2004EP1423519A2 G-protein coupled receptor and dna sequences thereof
06/02/2004EP1423514A2 Stable storage of proteins
06/02/2004EP1423511A2 Nucleic-acid associated proteins
06/02/2004EP1423510A2 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
06/02/2004EP1423432A2 Interleukin-1 beta antibodies
06/02/2004EP1423429A2 Antibodies against caspase-8, their preparation and use
06/02/2004EP1423427A2 Nogo receptor homologues and their use
06/02/2004EP1423426A1 Sut-2 and sut-3 genes, proteins and assays for inhibitors of lymphocyte adhesion
06/02/2004EP1423424A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology
06/02/2004EP1423422A2 A caspase- 8 binding protein, its preparation and use
06/02/2004EP1423417A2 Peptides mimicking a cryptic epitope of gp41 of hiv-1 and antibodies directed against them
06/02/2004EP1423415A2 Intracellular signaling molecules
06/02/2004EP1423414A1 Novel depsipeptides and process for preparing same
06/02/2004EP1423413A1 Peptidic compounds selectively binding to p-selectin
06/02/2004EP1423409A2 Gastrokines and derived peptides including inhibitors
06/02/2004EP1423405A2 Plasmodium falciparum ama-1 protein and uses thereof
06/02/2004EP1423400A2 Evolving new molecular function
06/02/2004EP1423191A1 Solid compositions for selective adsorption from complex mixtures
06/02/2004EP1423137A2 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
06/02/2004EP1423080A2 Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors
06/02/2004EP0981541B1 Psca: prostate stem cell antigen
06/02/2004EP0941334B1 Protease-activatable pseudomonas exotoxin a-like proproteins
06/02/2004EP0807178B1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis
06/02/2004EP0792279B1 Antibiotic cryptdin peptides and methods of their use
06/02/2004CN1500883A Process for producing casein peptide using coarse cheese as raw material
06/02/2004CN1500882A Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells
06/02/2004CN1500881A Process for producing soybean protein peptide using soybean as raw material
06/02/2004CN1500808A Recombination of human soluble TRAIL protein, the preparing method and the application in preparing antineoplastic medicine
06/02/2004CN1500806A HIV-lgp160 membrane protein, preparing method and uses thereof
06/02/2004CN1152053C Method for inducting and preparing epitope idiosyncratic monoclonal antibody using epitope polypeptide
06/02/2004CN1152051C Trichosanthin mutant and preparing method thereof
06/01/2004US6743908 For use in cancer diagnosis and therapy
06/01/2004US6743896 Protien for use in the treatment of infection and tumors
06/01/2004US6743778 Apo-AI/AII peptide derivatives
06/01/2004US6743622 Homologous recombination antibody expression system for murine cells
06/01/2004US6743619 For therapeutic, diagnostic and research use
06/01/2004US6743618 Thermostable proteolytic enzymes and uses thereof in peptide and protein synthesis
06/01/2004US6743617 Can be used against bacterial infections, as digestive enzyme in some mollusks which live on bacteria, anti-tumor agent
06/01/2004US6743603 Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof
06/01/2004US6743600 To yield proteins having their native amino acid sequences; in vitro
06/01/2004US6743594 Identifying antagonists and agonists for diagnosis and therapy
06/01/2004US6743577 Methods of using cyanovirins to inhibit viral infection
06/01/2004US6743431 Capsular polysaccharide adhesin antigen, preparation, purification and use
06/01/2004CA2170605C Mutants of the rb and p53 genes and uses thereof
06/01/2004CA2078571C Bacillus thuringiensis cryiiic gene and protein toxic to coleopteran insects
06/01/2004CA2063176C Process for the preparation of glutarylacylase in large quantities
06/01/2004CA2037677C Process for production of exogenous gene or its product in plant cells
06/01/2004CA2034034C Process for the production of antibodies
05/2004
05/29/2004CA2451584A1 Modified cdna factor viii and its derivatives
05/27/2004WO2004044555A2 Diagnosis of sepsis or sirs using biomarker profiles
05/27/2004WO2004044214A1 Novel substance fki-1033 and process for producing the same
05/27/2004WO2004044206A1 Plasmids expressing human insulin and the preparation method for human insuling thereby
05/27/2004WO2004044201A1 Signaling proteins participating in immunopotentiation by virus-origin double-stranded rna and endotoxin and genes thereof
05/27/2004WO2004044198A1 Antibodies recognizing chondroitin sulfate b and chondroitin sulfate e
05/27/2004WO2004044167A2 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide
05/27/2004WO2004044156A2 Transgenic ungulates having reduced prion protein activity and uses thereof
05/27/2004WO2004044008A1 Dna/rna transduction technology and its clinical and basic applications
05/27/2004WO2004044005A1 Kit for assaying human low-molecular weight cd14 and antibody
05/27/2004WO2004043989A2 Human monoclonal antibodies to heparanase
05/27/2004WO2004009762A3 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof
05/27/2004WO2003089455A3 Low-cost production of peptides
05/27/2004WO2003064608A9 Surface based translation system
05/27/2004WO2003046567A3 Protein biopolymer markers predictive of alzheimers disease
05/27/2004WO2003015705A3 In situ immunization
05/27/2004WO2003008541A8 Extracellular junctional adhesion molecules
05/27/2004WO2002092827A3 Corona-virus-like particles comprising functionally deleted genomes
05/27/2004WO2002085923A3 In vivo incorporation of unnatural amino acids
05/27/2004WO2002043478A8 Transgenic transchromosomal rodents for making human antibodies
05/27/2004WO1999046281A8 Novel polypeptides and nucleic acids encoding the same
05/27/2004US20040102613 For prophylactic/therapeutic drugs for heart/central nervous system diseases; diagnostic kits
05/27/2004US20040102379 Fibroblast growth factor homologous factors (FHFs) and methods of use
05/27/2004US20040102372 Therapeutic antiangiogenic compositions and methods
05/27/2004US20040101963 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus
05/27/2004US20040101947 A cationic or nonionic surfactant having a hydrophobic-lipophilic balance value from about 11 to 16 and a cell membrane altering compound, used for extracting a protein or peptide from target cell
05/27/2004US20040101934 Beverage comprising peptide nerve growth factor conjugate for use in treatment of pain; analgesics; tranquilizers
05/27/2004US20040101927 Comprises nucleotide sequences coding polypeptides for diagnosis, prognosis, prevention and treatment of neurodegenerative and cancer disorders
05/27/2004US20040101919 Detecting cell wall anchored surface proteins and developing vaccines to diagnose, prevent and treat enterococcus, streptococcus, staphylococcus and bacillus infections
05/27/2004US20040101910 Immunoglobulin capable of binding lymphocyte polypeptides for treatment and prevention of cell proliferative disorders; antitumor agents
05/27/2004US20040101882 Secreted proteins
05/27/2004US20040101875 Novel g protein-coupled receptor protein and dna thereof
05/27/2004US20040101833 Human TREK2, a stretch- and arachidonic acid-sensitive K+ channel activated by inhalational anesthetics and riluzole
05/27/2004US20040101831 Monoclonal antibodies to human immunodeficiency virus and uses thereof
05/27/2004US20040101536 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates
05/27/2004US20040101530 Separation of anticancer antibodies using cancer cell cytotoxicity; complexing antibodies; medical diagnosis
05/27/2004US20040101509 Chemokine mutants in the treatment of multiple sclerosis
05/27/2004DE19943919B4 Verfahren zur Steigerung der Ausbeute von rekombinanten Proteinen in mikrobiellen Fermentationsprozessen A method for increasing the yield of recombinant proteins in microbial fermentation processes
05/27/2004CA2505921A1 Diagnosis of sepsis or sirs using biomarker profiles
05/27/2004CA2504309A1 Novel substance fki-1033 and process for producing the same
05/27/2004CA2502490A1 Transgenic ungulates having reduced prion protein activity and uses thereof
05/26/2004EP1422294A1 Method of making an HPV18 L1 Expression Vector and HPV18 L1,L2 antibodies
05/26/2004EP1422243A1 HUMANIZED ANTIBODY AGAINST FIBROBLAST GROWTH FACTOR−8 AND FRAGMENT OF THE ANTIBODY
05/26/2004EP1422237A2 Methods for the recombinant production of antifusogenic peptides
05/26/2004EP1421951A2 Conserved motif of hepatitis C virus E2/NS1 region
05/26/2004EP1421947A1 p53 vaccine
05/26/2004EP1421539A2 Stabilized proteins with engineered disulfide bonds
05/26/2004EP1421388A2 Diagnosis of carcinomas
05/26/2004EP1421222A2 Cell culture system for synthesis of infectious hepatitis c virus
05/26/2004EP1421195A1 SURFACE EXPRESSION VECTORS HAVING pgsBCA, THE GENE CODING POLY-GAMMA-GLUTAMATE SYNTHETASE, AND A METHOD FOR EXPRESSION OF TARGET PROTEIN AT THE SURFACE OF MICROORGANISM USING THE VECTOR
05/26/2004EP1421191A2 Therapeutic binding molecules